IL292594A - Training with a high salt load in cation exchange chromatography to remove impurities associated with the product - Google Patents

Training with a high salt load in cation exchange chromatography to remove impurities associated with the product

Info

Publication number
IL292594A
IL292594A IL292594A IL29259422A IL292594A IL 292594 A IL292594 A IL 292594A IL 292594 A IL292594 A IL 292594A IL 29259422 A IL29259422 A IL 29259422A IL 292594 A IL292594 A IL 292594A
Authority
IL
Israel
Prior art keywords
sodium chloride
buffer comprises
acetate
cation exchange
wash buffer
Prior art date
Application number
IL292594A
Other languages
English (en)
Hebrew (he)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of IL292594A publication Critical patent/IL292594A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL292594A 2019-11-07 2020-11-04 Training with a high salt load in cation exchange chromatography to remove impurities associated with the product IL292594A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962931863P 2019-11-07 2019-11-07
PCT/US2020/058772 WO2021091932A1 (en) 2019-11-07 2020-11-04 High salt load conditioning during cation exchange chromatography to remove product-realated impurities

Publications (1)

Publication Number Publication Date
IL292594A true IL292594A (en) 2022-07-01

Family

ID=73598211

Family Applications (1)

Application Number Title Priority Date Filing Date
IL292594A IL292594A (en) 2019-11-07 2020-11-04 Training with a high salt load in cation exchange chromatography to remove impurities associated with the product

Country Status (13)

Country Link
US (1) US20220372070A1 (https=)
EP (1) EP4055041A1 (https=)
JP (2) JP7760500B2 (https=)
KR (1) KR20220092969A (https=)
CN (1) CN114746441A (https=)
AU (1) AU2020380256A1 (https=)
BR (1) BR112022008649A2 (https=)
CA (1) CA3160143A1 (https=)
CL (3) CL2022001168A1 (https=)
IL (1) IL292594A (https=)
MX (1) MX2022005593A (https=)
WO (1) WO2021091932A1 (https=)
ZA (1) ZA202205010B (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019970A2 (en) * 1999-09-15 2001-03-22 Eli Lilly And Company Chymotrypsin-free trypsin
CA2645739A1 (en) * 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
EP2009101B1 (en) * 2006-03-31 2017-10-25 Chugai Seiyaku Kabushiki Kaisha Antibody modification method for purifying bispecific antibody
CN104628846B (zh) * 2013-11-06 2019-12-06 三生国健药业（上海）股份有限公司 重组蛋白质的纯化方法
US9611325B2 (en) * 2014-07-21 2017-04-04 Wuhan Yzy Biopharma Co., Ltd. Construction and application of bispecific antibody HER2xCD3
EP3204415B1 (en) * 2014-10-09 2020-06-17 EngMab Sàrl Bispecific antibodies against cd3epsilon and ror1
JP6699085B2 (ja) * 2015-03-25 2020-05-27 東ソー株式会社 Ｆｃ結合性タンパク質の精製方法
CN119161488A (zh) * 2017-11-01 2024-12-20 中外制药株式会社 具有降低的生物活性的抗体变体和同种型
CN110305217B (zh) * 2018-03-27 2022-03-29 广州爱思迈生物医药科技有限公司 双特异性抗体及其应用

Also Published As

Publication number Publication date
CL2022001168A1 (es) 2023-01-27
EP4055041A1 (en) 2022-09-14
MX2022005593A (es) 2022-06-09
WO2021091932A1 (en) 2021-05-14
CL2024001788A1 (es) 2024-09-27
JP2022554282A (ja) 2022-12-28
AU2020380256A1 (en) 2022-06-09
CL2025003712A1 (es) 2026-01-09
KR20220092969A (ko) 2022-07-04
JP7760500B2 (ja) 2025-10-27
CN114746441A (zh) 2022-07-12
BR112022008649A2 (pt) 2022-07-19
CA3160143A1 (en) 2021-05-14
US20220372070A1 (en) 2022-11-24
ZA202205010B (en) 2023-01-25
JP2026012744A (ja) 2026-01-27

Similar Documents

Publication Publication Date Title
US20220119526A1 (en) A continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes
WO2022072291A1 (en) Cation exchange chromatography process
US20230058276A1 (en) Methods for harvesting biomolecules
JP2026048656A (ja) 生成物関連不純物を除去するためのカチオン交換クロマトグラフィー中の高塩分洗浄
US20240174752A1 (en) Modulating product quality of asymmetric multispecific antibodies through the use of temperature
JP7760500B2 (ja) 生成物関連不純物を除去するためのカチオン交換クロマトグラフィー中の高塩分負荷コンディショニング
US20260070943A1 (en) A method for harvesting products from high cell density perfusion cell cultures
CN120882878A (zh) 制备重组il-12白蛋白结合结构域融合蛋白的方法
EA047099B1 (ru) Кондиционирование с высокой солевой нагрузкой в ходе катионообменной хроматографии для удаления связанных с продуктом примесей
EA046702B1 (ru) Способы очистки биспецифических антител при помощи катионообменной хроматографии с использованием промывки с высоким содержанием соли
HK40070045A (en) High salt load conditioning during cation exchange chromatography to remove product-realated impurities
HK40070589A (en) High salt washes during cation exchange chromatography to remove product-realated impurities
WO2025251034A1 (en) Purification method
JP2026505293A (ja) 細胞培養法